In the BioHarmony Drug Report Database

"Preview" Icon

Methyltestosterone

Metandren, Oreton Methyl (methyltestosterone) is a small molecule pharmaceutical. Methyltestosterone was first approved as Metandren on 1982-01-01. It is used to treat breast neoplasms, delayed puberty, erectile dysfunction, and hypogonadism in the USA. The pharmaceutical is active against androgen receptor.

 

Trade Name

 

Metandren, Oreton Methyl
 

Common Name

 

methyltestosterone
 

ChEMBL ID

 

CHEMBL1395
 

Indication

 

breast neoplasms, delayed puberty, erectile dysfunction, hypogonadism
 

Drug Class

 

Steroids (androgens, anabolics)

Image (chem structure or protein)

Methyltestosterone structure rendering